Stockscreener 앱 받기
2.24
0.00%
0.00
시간 외 거래:
2.22
-0.02
-0.89%
전일 마감가:
$2.24
열려 있는:
$2.23
하루 거래량:
13,023
Relative Volume:
0.00
시가총액:
$4.48M
수익:
$4.96M
순이익/손실:
$-6.82M
주가수익비율:
-0.0343
EPS:
-65.4
순현금흐름:
$-6.64M
1주 성능:
-6.28%
1개월 성능:
-18.84%
6개월 성능:
-29.34%
1년 성능:
-20.57%
1일 변동 폭
$2.20
$2.24
1주일 범위
$2.20
$2.39
52주 변동 폭
$1.72
$15.70
Inmed Pharmaceuticals Inc Stock (INM) Company Profile
명칭
Inmed Pharmaceuticals Inc
전화
(604) 669-7207
주소
1445-885 WEST GEORGIA ST., VANCOUVER
INM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
INM
Inmed Pharmaceuticals Inc
|
2.24 | 4.54M | 4.96M | -6.82M | -6.64M | -65.40 |
|
ZTS
Zoetis Inc
|
147.35 | 64.93B | 9.39B | 2.61B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.44 | 45.07B | 29.98B | 958.27M | 5.31B | 0.2964 |
|
HLN
Haleon Plc Adr
|
9.54 | 41.53B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.37 | 18.37B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
301.50 | 13.68B | 2.99B | 1.21B | 1.13B | 25.06 |
Inmed Pharmaceuticals Inc 주식(INM)의 최신 뉴스
InMed Pharmaceuticals Inc. stock outlook for YEARFundamental Forecast for Undervalued Stocks - Newser
Published on: 2025-08-10 20:48:17 - Newser
What makes InMed Pharmaceuticals Inc. stock price move sharplyTechnical Long-Term Outlook and Recap Guide - Newser
Exit strategy if you’re trapped in InMed Pharmaceuticals Inc.Early Buy Opportunity with Chart Triggers - Newser
News impact scoring models applied to InMed Pharmaceuticals Inc.Short Term Opportunity Finder with Tools - Newser
Quantitative breakdown of InMed Pharmaceuticals Inc. recent moveFree Strong Buy With Technical Confidence - Newser
Using RSI to spot recovery in InMed Pharmaceuticals Inc.High Probability Trade Plan with Indicators - Newser
What MACD and RSI say about InMed Pharmaceuticals Inc.Trade Ideas Based on Fundamental Metrics - Newser
Strategies to average down on InMed Pharmaceuticals Inc.Machine Learning Intraday Signal Forecast - Newser
Tick level data insight on InMed Pharmaceuticals Inc. volatilityFree Buy Signal Based on Chart Analysis - Newser
Using R and stats models for InMed Pharmaceuticals Inc. forecastingNext Day Momentum Stock Forecasting Report - Newser
Custom strategy builders for tracking InMed Pharmaceuticals Inc.Free Real-Time Analysis With Entry Targets - Newser
Will InMed Pharmaceuticals Inc. outperform the marketDaily Market Momentum and Pressure Analysis - Newser
What are InMed Pharmaceuticals Inc. company’s key revenue driversUnlock steady growth with low-risk stocks - Jammu Links News
Why InMed Pharmaceuticals Inc. stock attracts strong analyst attentionFree Conservative Entry for High Return Setup - Newser
Is it the right time to buy InMed Pharmaceuticals Inc. stockAccess daily stock market expert updates - Jammu Links News
What institutional investors are buying InMed Pharmaceuticals Inc. stockBuild wealth faster with professional insights - Jammu Links News
Does InMed Pharmaceuticals Inc. stock perform well during market downturnsHigh-octane gains - Jammu Links News
What are analysts’ price targets for InMed Pharmaceuticals Inc. in the next 12 monthsMaximize gains with professional stock picks - Jammu Links News
Is InMed Pharmaceuticals Inc. a good long term investmentAccelerate your capital gains today - Jammu Links News
What analysts say about InMed Pharmaceuticals Inc. stockFree Trading Strategy Suggestions - Jammu Links News
How volatile is InMed Pharmaceuticals Inc. stock compared to the marketCapitalize on momentum-driven investment opportunities - Jammu Links News
What is the risk reward ratio of investing in InMed Pharmaceuticals Inc. stockUnstoppable profit momentum - Jammu Links News
News impact scoring models applied to InMed Pharmaceuticals IncShort Term Gain Strategy with AI Logic - Newser
What moving averages say about InMed Pharmaceuticals Inc.Free Early Entry Tips With Low Risk Zone - Newser
How InMed Pharmaceuticals Inc. stock performs during market volatilityAI Screener Based Stock Summary Report - Newser
Inmed Pharmaceuticals Inc (INM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.43%
0.47%
자본화:
|
볼륨(24시간):